跳至主要内容
临床试验/JPRN-UMIN000000525
JPRN-UMIN000000525未知未知

Olmesartan-based versus Amlodipine-based Strategies for Circulating Marker Modification in Essential Hypertension Study - OASES Study

Department of Cardiovascular Medicine, Kyoto University Hospital0 个研究点目标入组 400 人开始时间: 2006年11月21日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Cerebrovascular and cardiovascular events including myocardial infarction, cerebral infarction, cerebral hemorrahge and subarchnoidal hemorrahge within 6 months. 2.PTCA or CABG performed within 6 months. 3.Scheduled PTCA or CABG in the future. 4.Congenital or rheumatic heart disease. 5.Severe arrhythmia. 6.Severe liver insufficiency. 7.Severe renal insufficiency. 8.Active cancer or treatment for cancer within 5 years. 9.Pregnancy, possible pregnancy. 10.Not suitable to the clinical trial as judged by a physician.

研究者

发起方
Department of Cardiovascular Medicine, Kyoto University Hospital

相似试验